| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011080 |
| Receipt No. | R000012970 |
| Official scientific title of the study | Robotic surgery for Achalasia |
| Date of disclosure of the study information | 2013/06/30 |
| Last modified on | 2016/07/01 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Robotic surgery for Achalasia | |
| Title of the study (Brief title) | Robotic surgery for Achalasia | |
| Region |
|
|
| Condition | ||
| Condition | Achalasia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of safety and efficiency of robotic surgery for achalasia |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | safety and efficiency |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Robotic surgery | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Esophageal achalasia
2. Age: 20 and more, 79 or younger. 3.Performance Status (ECOG):0 or1 4.At least 4 weeks has been past since previous treatments 5.Appropriate organ functions are preserved. |
|||
| Key exclusion criteria | 1. Obvious infection
2. Severe hypo alimentation 3. Uncontrorable pleural effusion, ascites, pericardial effusion 4. Severe heart failure 5. Severe complication 6. Psychiatric disorders 7. Active cancers 8. Steroid usage 9. Hepatitis, HIV positive, HTLV-1 Positive 10. Hyper sensitivity for albumin 11. Pregnant woman 12. Autoimmune diseases |
|||
| Target sample size | 5 | |||
| Research contact person | |
| Name of lead principal investigator | Hisahiro Matsubara |
| Organization | Chiba University |
| Division name | Department of GI-Surgery |
| Address | 1-8-1, Inohana, Chuoku, Chiba |
| TEL | 043-222-7171 |
| matsuhm@faculty.chiba-u.jp | |
| Public contact | |
| Name of contact person | Yasunori Akutsu |
| Organization | Chiba University |
| Division name | Department of Frontier Surgery |
| Address | 1-8-1, Inohana, Chuoku, Chiba |
| TEL | 043-226-2110 |
| Homepage URL | |
| yakutsu@faculty.chiba-u.jp | |
| Sponsor | |
| Institute | Chiba University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012970 |